Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Hollister Biosciences

CSE: HOLL | OTC: HSTRF | FWB: HOB

Canadian cannabis firm Hollister Biosciences entered into a definitive agreement to acquire Alphamind Brands, and closed the acquisition in April 2020. Alphamind are conducting R&D into psilocybin-based drug therapies, seeking to build an IP portfolio in the psychedelic medicine space.

[mstock id="3020"]

[mstock id="3021"]

Latest News

Hollister Bioscience’s 100% Owned Subsidiary Venom Extracts Generates Record Monthly Revenue in May 2020

June 11, 2020

Hollister Biosciences Inc. Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal Mushroom Based Product Line

June 4, 2020

Hollister Biosciences Inc. CEO Provides Corporate Update

May 14, 2020

Cannabis Company Hollister Biosciences Signs Letter of Intent to Acquire Mushroom-based Health Company Alphamind Brands

March 13, 2020

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.